Critical Care Therapeutics: Global Strategic Business Report

Global Critical Care Therapeutics Market to Reach $7.4 Billion by 2030

The global market for Critical Care Therapeutics estimated at US$4.8 Billion in the year 2022, is projected to reach a revised size of US$7.4 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2022-2030. Albumin, one of the segments analyzed in the report, is projected to record 6.8% CAGR and reach US$3.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Prothrombin Complex Concentrates segment is readjusted to a revised 4.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 9% CAGR

The Critical Care Therapeutics market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 4.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Select Competitors (Total 37 Featured) -

• Abeona Therapeutics Inc.
• ADMA Biologics, Inc.
• Albumedix Ltd.
• Asklepios Biopharmaceutical, Inc.
• Aspen Pharmacare Holdings Ltd.
• Baxter International Inc.
• Bayer Healthcare AG
• Bio Products Laboratory Ltd.
• BioDelivery Sciences International, Inc.
• Biogen, Inc.
• BioMarin Pharmaceutical Inc.
• Biotest Pharmaceuticals Corporation
• Bristol-Myers Squibb Company
• Catalyst Biosciences, Inc.
• China Biologic Products Holdings, Inc.
• Cosmo Pharmaceuticals NV
• CSL Behring
• Grifols International SA
• Kamada Ltd.
• Kedrion Biopharma, Inc.
• Medxbio Pte. Ltd.
• Merck & Co., Inc.
• Mitsubishi Tanabe Pharma Corporation
• Novo Nordisk A/S
• Novozymes A/S
• Octapharma AG
• Portola Pharmaceuticals, Inc.
• ProMetic Life Sciences, Inc.
• rEVO Biologics, Inc.
• Rockwell Medical
• Sanquin
• Shanghai RAAS Blood Products Co., Ltd.
• Shire PLC
• Teva Pharmaceutical Industries Ltd.
• The Medicines Company
• Thermo Fisher Scientific, Inc.
• Ventria Bioscience

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year